uric acid has been researched along with atenolol in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (47.06) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gudbrandsson, T; Hansson, L | 1 |
| Hagelund, CH; Helgeland, A; Strømmen, R; Tretli, S | 1 |
| Lehtonen, A | 1 |
| Heath, ID; Larkin, H; Stanley, NN; Thirkettle, JL; Varma, MP | 1 |
| Davidoff, R; Myburgh, DP; Schamroth, CL; Schamroth, JM | 1 |
| Brandstetter, G; Hoffmann, H | 1 |
| Schoeman, HS; Sommers, DK; van Wyk, M | 1 |
| Aakesson, I; Eide, I; Kjeldsen, SE; Leren, P; Os, I; Skjøtø, J | 1 |
| Fogari, R; Malamani, GD; Marasi, G; Vanasia, A; Villa, G; Zoppi, A | 1 |
| Berglund, E; Dahlöf, C; Engqvist, L; Lagerstedt, C; Lehtonen, A; Nilsson-Ehle, P; Thulin, T | 1 |
| Applegate, WB; Di Bari, M; Franse, LV; Pahor, M; Shorr, RI; Somes, GW; Wan, JY | 1 |
| Chen, C; Snapinn, SM; Wang, H | 1 |
| Alderman, MH; Chen, C; Dahlöf, B; De Faire, U; Devereux, RB; Fyhrquist, F; Høieggen, A; Ibsen, H; Julius, S; Kjeldsen, SE; Kristianson, K; Lederballe-Pedersen, O; Lindholm, LH; Nieminen, MS; Omvik, P; Oparil, S; Wedel, H | 1 |
| Dahlöf, B; Devereux, RB; Høieggen, A; Ibsen, H; Kjeldsen, SE; Larstorp, AC; Lindholm, L; Okin, PM; Olsen, MH; Wachtell, K; Wiik, BP | 1 |
| Bailey, K; Beitelshees, AL; Boerwinkle, E; Chapman, AB; Cooper-DeHoff, RM; Gong, Y; Gums, JG; Johnson, JA; Smith, SM; Turner, ST | 1 |
| Carr, M; Damian, DJ; McNamee, R | 1 |
| Bombelli, M; Cuspidi, C; Facchetti, R; Grassi, G; Macchiarulo, M; Maggiolini, D; Mancia, G; Parati, G | 1 |
15 trial(s) available for uric acid and atenolol
| Article | Year |
|---|---|
Combination therapy with saluretics and atenolol in essential hypertension. Effects on blood pressure, electrolytes and uric acid.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Bendroflumethiazide; Chlorthalidone; Diuretics; Drug Evaluation; Drug Therapy, Combination; Electrolytes; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Mefruside; Middle Aged; Propanolamines; Uric Acid | 1979 |
Enalapril, atenolol, and hydrochlorothiazide in mild to moderate hypertension. A comparative multicentre study in general practice in Norway.
Topics: Adult; Aged; Atenolol; Blood Glucose; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Enalapril; Female; Headache; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Muscle Hypotonia; Potassium; Random Allocation; Time Factors; Uric Acid | 1986 |
Comparison of the metabolic effects of long-term treatment with pindolol or atenolol by hypertensive patients.
Topics: Adult; Atenolol; Blood Glucose; Body Weight; Cholesterol, LDL; Cholesterol, VLDL; Drug Administration Schedule; Female; Humans; Hypertension; Insulin; Lipids; Male; Pindolol; Time Factors; Triglycerides; Uric Acid | 1988 |
Efficacy and tolerability of atenolol, nifedipine and their combination in the management of hypertension.
Topics: Adult; Aged; Atenolol; Blood Pressure; Clinical Trials as Topic; Creatinine; Double-Blind Method; Drug Therapy, Combination; Drug Tolerance; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nifedipine; Potassium; Random Allocation; Uric Acid | 1988 |
[Treatment of hypertensive hyperuricemic patients with a new beta blocker-diuretic combination].
Topics: Adult; Aged; Atenolol; Celiprolol; Chlorthalidone; Drug Combinations; Drug Tolerance; Female; Humans; Hypertension; Male; Middle Aged; Propanolamines; Uric Acid | 1984 |
The effects of two combinations of a beta-blocker and a diuretic on diuresis in normal subjects.
Topics: Adult; Atenolol; Chlorthalidone; Clinical Trials as Topic; Diuresis; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Male; Potassium; Sodium; Sotalol; Uric Acid; Urine | 1984 |
Increased plasma vasopressin and serum uric acid in the low renin type of essential hypertension.
Topics: Atenolol; Blood Pressure; Body Weight; Catecholamines; Heart Rate; Humans; Hypertension; Male; Middle Aged; Oxprenolol; Renin; Uric Acid; Vasopressins | 1984 |
Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients.
Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Fibrinogen; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Potassium; Triglycerides; Uric Acid | 1995 |
Long-term effects of diltiazem and atenolol on blood glucose, serum lipids, and serum urate in hypertensive patients. Swedish-Finnish Study Group.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Glucose; Captopril; Diltiazem; Humans; Hypertension; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Middle Aged; Quality of Life; Single-Blind Method; Time Factors; Uric Acid | 1999 |
Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP).
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Atenolol; Biomarkers; Cardiovascular Diseases; Chlorthalidone; Cohort Studies; Diuretics; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Longitudinal Studies; Male; Middle Aged; Reserpine; Stroke; Uric Acid | 2000 |
The impact of serum uric acid on cardiovascular outcomes in the LIFE study.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Creatinine; Endpoint Determination; Female; Follow-Up Studies; Hemoglobins; Humans; Hypertension, Renal; Losartan; Male; Middle Aged; Proportional Hazards Models; Risk Factors; Treatment Outcome; Uric Acid | 2004 |
Serum uric acid is associated with new-onset diabetes in hypertensive patients with left ventricular hypertrophy: The LIFE Study.
Topics: Aged; Antihypertensive Agents; Atenolol; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Risk Factors; Uric Acid | 2010 |
Blood pressure responses and metabolic effects of hydrochlorothiazide and atenolol.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Triglycerides; Uric Acid | 2012 |
Changes in selected metabolic parameters in patients over 65 receiving hydrochlorothiazide plus amiloride, atenolol or placebo in the MRC elderly trial.
Topics: Adrenergic beta-1 Receptor Antagonists; Age Factors; Aged; Amiloride; Antihypertensive Agents; Atenolol; Biomarkers; Blood Glucose; Body Weight; Cholesterol; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Intention to Treat Analysis; Linear Models; Male; Potassium; Single-Blind Method; Sodium; Sodium Chloride Symporter Inhibitors; Time Factors; Treatment Outcome; United Kingdom; Urea; Uric Acid | 2016 |
Serum uric acid and resistance to antihypertensive treatment: data from the European Lacidipine Study on Atherosclerosis.
Topics: Antihypertensive Agents; Atenolol; Atherosclerosis; Blood Pressure; Carotid Artery Diseases; Dihydropyridines; Disease Progression; Double-Blind Method; Drug Resistance; Female; Humans; Hypertension; Male; Middle Aged; Uric Acid | 2019 |
2 other study(ies) available for uric acid and atenolol
| Article | Year |
|---|---|
Beta adrenergic blocking agents to control hypertension in aviation personnel.
Topics: Adrenergic beta-Antagonists; Adult; Aerospace Medicine; Atenolol; Humans; Hypertension; Male; Middle Aged; Propanolamines; Uric Acid | 1982 |
Proportion of treatment effect (PTE) explained by a surrogate marker.
Topics: Antihypertensive Agents; Atenolol; Biomarkers; Confidence Intervals; Data Interpretation, Statistical; Humans; Hypertension; Losartan; Models, Statistical; Monte Carlo Method; Treatment Outcome; Uric Acid | 2003 |